Ledger.Open graph →
SEC Form D · Amendment · filed February 16, 2017

Checkmate Pharmaceuticals, Inc

Offering
$25.0M
Sold
$25.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
CAMBRIDGE, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (12)

Michael A. Powell · Cambridge, MADirectorChuck A. Abdalian · Cambridge, MAExecArthur A. Krieg · Cambridge, MAExec · DirectorCorey A. Goodman · Cambridge, MADirectorRandall H. Guthrie · Colorado Springs, COExecJean A. Pineault · Colorado Springs, CODirectorArthur A. Krieg · Cambridge, MAExec · DirectorJohn A. Gloriod · Colorado Springs, CODirectorScott K. Bessent · New York, NYDirectorBryan Frisina · ALISO VIEJO, CAExec · DirectorDean P. Stull · Colorado Springs, COExecMichael K. Germino · New York, NYDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗